In life science, every new drug or medical device springs from the drive to improve human health. In 1998, Laurie Halloran realized that the life science companies she worked with needed senior-level expertise to navigate the regulatory, clinical, and operational challenges facing each stage of development.
Halloran Consulting Group, with a growing team of industry experts, can help you find a solution.
President and Chief Executive Officer
Chief Operating Officer
Phil Lacari, MBA
FDA has a new reporting tool to catch regulatory misconduct
Device manufacturers beware! FDA recently released a reporting tool to supplement their compliance oversight resources. Through FDA’s website, anyone can complete and submit a form to report allegations of regulatory misconduct.
Ask the Thought Leaders: What’s The Future Of Healthcare?
The state of the healthcare industry in 15 years will be directly related to what happens in our government in the next year or two. If I were being optimistic, my projection would be that the enablement and widespread evolution and integration of mobile applications for health maintenance and cost containment will enable patients to take even more control of their healthcare.